Catalyst Pharmaceuticals
Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.
CPRX Key Statistics
Stock Snapshot
Catalyst Pharmaceuticals(CPRX) stock is priced at $23.43, giving the company a market capitalization of 2.88B. It carries a P/E multiple of 13.67.
On 2025-11-27, Catalyst Pharmaceuticals(CPRX) stock traded between a low of $23.01 and a high of $23.72. Shares are currently priced at $23.43, which is +1.8% above the low and -1.2% below the high.
Catalyst Pharmaceuticals(CPRX) shares are trading with a volume of 1.39M, against a daily average of 1.28M.
During the past year, Catalyst Pharmaceuticals(CPRX) stock moved between $19.05 at its lowest and $26.58 at its peak.
During the past year, Catalyst Pharmaceuticals(CPRX) stock moved between $19.05 at its lowest and $26.58 at its peak.
CPRX News
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare invest...
Catalyst Pharmaceuticals was recently ranked 304th on the 2025 Deloitte Technology Fast 500™, based on very large revenue growth of 249% from fiscal 2021 to 202...
